Posted by med_empowered on October 18, 2005, at 3:38:11
In reply to Re: NRP104 - D-amphetamine bonded with Lysine?, posted by Shawn. T. on October 17, 2005, at 11:53:08
this company is trying to achieve the holy grail of ADHD treatment: effiacy and proven track record of the old-school stims, with less abuse potential and re-fillable prescriptions (improves public perception, reduces problems and paperwork). My wild guess would be that, if it is proven to be less addictive than usual dextroamphetamine, they may be able to get schedule IV status, maybe with a situation like what happened with Ultram (it was and is schedul V, uncontrolled; the company set up and paid for a monitoring program, which reported to the FDA, to investigate and analyze post-marketing abuse/misuse problems). I'm kind of wondering...do you think this will mean that this version of dextroamphetamine will be less affected by the presence/absence of foods (especially fatty ones) and other substances (acidifying agents) ? That's be **great**.
poster:med_empowered
thread:567520
URL: http://www.dr-bob.org/babble/20051017/msgs/568435.html